# Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine

> **NCT03762785** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 16 (estimated)

## Conditions studied

- Abdominal Cancer

## Interventions

- **DRUG:** nebulized Dexmedetomidine

## Key facts

- **NCT ID:** NCT03762785
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-10
- **Primary completion:** 2020-01
- **Final completion:** 2021-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03762785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03762785, "Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03762785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*